168 related articles for article (PubMed ID: 9704164)
21. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
Dunner DL
J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
[TBL] [Abstract][Full Text] [Related]
22. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
Dardennes R; Lafuma A; Watkins S
Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
[TBL] [Abstract][Full Text] [Related]
23. Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
Bowden CL
J Clin Psychiatry; 1999; 60 Suppl 5():3-4. PubMed ID: 10192401
[No Abstract] [Full Text] [Related]
24. New developments in the use of anticonvulsants as mood stabilizers.
Post RM; Ketter TA; Pazzaglia PJ; George MS; Marangell L; Denicoff K
Neuropsychobiology; 1993; 27(3):132-7. PubMed ID: 8232827
[TBL] [Abstract][Full Text] [Related]
25. [Anticonvulsants treatment of psychiatric disorder in elderly patients].
Bidzan L
Przegl Lek; 2006; 63(7):583-7. PubMed ID: 17203814
[TBL] [Abstract][Full Text] [Related]
26. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
Keck PE; McElroy SL
J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of mood stabilizers and new anticonvulsants.
Wang PW; Ketter TA
Psychopharmacol Bull; 2002; 36(1):44-66. PubMed ID: 12397847
[TBL] [Abstract][Full Text] [Related]
28. Long-term pharmacological treatment of bipolar disorders.
Rybakowski J
Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():71-93. PubMed ID: 17262006
[TBL] [Abstract][Full Text] [Related]
29. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
Ketter TA; Nasrallah HA; Fagiolini A
Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
[TBL] [Abstract][Full Text] [Related]
30. Oxcarbazepine in affective and schizoaffective disorders.
Dietrich DE; Kropp S; Emrich HM
Pharmacopsychiatry; 2001 Nov; 34(6):242-50. PubMed ID: 11778145
[TBL] [Abstract][Full Text] [Related]
31. A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century.
Post RM; Denicoff KD; Frye MA; Dunn RT; Leverich GS; Osuch E; Speer A
Neuropsychobiology; 1998 Oct; 38(3):152-66. PubMed ID: 9778604
[TBL] [Abstract][Full Text] [Related]
32. Anticonvulsants in the treatment of mood disorders: assessing current and future roles.
Gilmer WS
Expert Opin Pharmacother; 2001 Oct; 2(10):1597-608. PubMed ID: 11825302
[TBL] [Abstract][Full Text] [Related]
33. [Antiepileptic drugs in the control of the impulses disorders].
Roncero C; Rodríguez-Urrutia A; Grau-López L; Casas M
Actas Esp Psiquiatr; 2009; 37(4):205-12. PubMed ID: 19927233
[TBL] [Abstract][Full Text] [Related]
34. Role of mood stabilizers in bipolar disorder.
Bhagwagar Z; Goodwin GM
Expert Rev Neurother; 2002 Mar; 2(2):239-48. PubMed ID: 19811005
[TBL] [Abstract][Full Text] [Related]
35. Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.
Bachmann RF; Schloesser RJ; Gould TD; Manji HK
Mol Neurobiol; 2005 Oct; 32(2):173-202. PubMed ID: 16215281
[TBL] [Abstract][Full Text] [Related]
36. [Current trends in the therapeutic use of thymic regulators].
Dardennes R; Even C
Presse Med; 1998 Dec; 27(40):2157-63. PubMed ID: 9922794
[TBL] [Abstract][Full Text] [Related]
37. [Mood regulator agents (excluding lithium)].
Rouillon F
Rev Prat; 1994 Nov; 44(17):2307-10. PubMed ID: 7984937
[TBL] [Abstract][Full Text] [Related]
38. Choosing lithium, anticonvulsant, or electroconvulsant therapy for mood disorders.
Reeves RR; Nixon FE
South Med J; 1995 Feb; 88(2):248-9; author reply 250. PubMed ID: 7839178
[No Abstract] [Full Text] [Related]
39. Sensitization and oscillation following repeated stimulation: relationship to affective illness and its treatment with lithium and carbamazepine [proceedings].
Post RM
Psychopharmacol Bull; 1980 Oct; 16(4):50-2. PubMed ID: 7454937
[No Abstract] [Full Text] [Related]
40. [Calcium antagonistic actions of drugs used in treatment of affective disorders].
Langosch JM; Walden J
Fortschr Neurol Psychiatr; 1998 Dec; 66(12):570-9. PubMed ID: 9922929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
